Exchange Traded Concepts, LLC Biomarin Pharmaceutical Inc Transaction History

Exchange Traded Concepts, LLC

  • $4.18 Billion
  • Q3 2024

A detailed history of Exchange Traded Concepts, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 16,663 shares of BMRN stock, worth $1.11 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
16,663
Previous 8,903 87.16%
Holding current value
$1.11 Million
Previous $732,000 59.97%
% of portfolio
0.03%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024
BUY
$69.02 - $93.84 $535,595 - $728,198
7,760 Added 87.16%
16,663 $1.17 Million
Q2 2024

Aug 13, 2024
SELL
$74.43 - $92.22 $9,229 - $11,435
-124 Reduced 1.37%
8,903 $732,000
Q1 2024

Apr 15, 2024
BUY
$83.81 - $99.0 $67,886 - $80,190
810 Added 9.86%
9,027 $788,000
Q4 2023

Jan 05, 2024
SELL
$76.22 - $98.51 $141,388 - $182,736
-1,855 Reduced 18.42%
8,217 $792,000
Q3 2023

Oct 18, 2023
SELL
$85.07 - $94.48 $145,639 - $161,749
-1,712 Reduced 14.53%
10,072 $891,000
Q2 2023

Jul 20, 2023
BUY
$86.68 - $100.3 $55,388 - $64,091
639 Added 5.73%
11,784 $1.02 Million
Q1 2023

Apr 12, 2023
BUY
$87.74 - $117.27 $1,754 - $2,345
20 Added 0.18%
11,145 $1.08 Million
Q4 2022

Jan 17, 2023
SELL
$80.93 - $108.63 $120,342 - $161,532
-1,487 Reduced 11.79%
11,125 $1.15 Million
Q3 2022

Oct 07, 2022
SELL
$82.16 - $96.94 $220,681 - $260,380
-2,686 Reduced 17.56%
12,612 $1.07 Million
Q2 2022

Jul 20, 2022
SELL
$71.48 - $86.85 $323,661 - $393,256
-4,528 Reduced 22.84%
15,298 $1.27 Million
Q1 2022

Apr 26, 2022
SELL
$74.28 - $92.69 $412,773 - $515,078
-5,557 Reduced 21.89%
19,826 $1.53 Million
Q4 2021

Jan 13, 2022
SELL
$71.72 - $91.47 $456,426 - $582,115
-6,364 Reduced 20.05%
25,383 $2.24 Million
Q3 2021

Oct 18, 2021
BUY
$74.77 - $85.47 $39,478 - $45,128
528 Added 1.69%
31,747 $2.45 Million
Q2 2021

Jul 30, 2021
BUY
$75.51 - $84.79 $277,197 - $311,264
3,671 Added 13.33%
31,219 $2.61 Million
Q1 2021

Apr 20, 2021
BUY
$74.73 - $90.69 $822,926 - $998,678
11,012 Added 66.59%
27,548 $2.08 Million
Q4 2020

Jan 19, 2021
BUY
$72.61 - $90.2 $762,695 - $947,460
10,504 Added 174.14%
16,536 $1.45 Million
Q3 2020

Oct 30, 2020
BUY
$71.87 - $131.03 $252,982 - $461,225
3,520 Added 140.13%
6,032 $459,000
Q2 2020

Jul 15, 2020
BUY
$79.55 - $124.22 $102,380 - $159,871
1,287 Added 105.06%
2,512 $310,000
Q1 2020

Apr 14, 2020
BUY
$71.37 - $96.85 $24,979 - $33,897
350 Added 40.0%
1,225 $104,000
Q4 2019

Jan 22, 2020
BUY
$64.27 - $86.37 $56,236 - $75,573
875 New
875 $74,000

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email